Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why Opendoor Technologies Stock Crashed Today (Fool) +++ OPENDOOR Aktie +3,75%

PCI BIOTECH Aktie

>PCI BIOTECH Performance
1 Woche: +1,9%
1 Monat: -69,6%
3 Monate: -74,6%
6 Monate: -67,3%
1 Jahr: -79,8%
laufendes Jahr: -67,5%
>PCI BIOTECH Aktie
Name:  PCI BIOTECH ASA NK 0,03
Land:  Norwegen
Sektor:  Gesundheit
ISIN/ Wkn:  NO0010405640 / A0Q2FS
Symbol/ Ticker:  4QG (Frankfurt)
Kürzel:  FRA:4QG, ETR:4QG, 4QG:GR
Index:  -
Webseite:  https://www.pcibiotech.no..
Profil:  PCI Biotech Holding ASA is a biotechnology company..
>Volltext..
Marktkapitalisierung:  1.3 Mio. EUR
Unternehmenswert:  0.15 Mio. EUR
Umsatz:  -
EBITDA:  -2.19 Mio. EUR
Nettogewinn:  -1.74 Mio. EUR
Gewinn je Aktie:  -0.05 EUR
Schulden:  0.02 Mio. EUR
Liquide Mittel:  1.15 Mio. EUR
Operativer Cashflow:  -1.34 Mio. EUR
Bargeldquote:  2.27
Umsatzwachstum:  -
Gewinnwachstum:  29.44%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  PCI BIOTECH
Letzte Datenerhebung:  12.09.25
>PCI BIOTECH Kennzahlen
Aktien/ Unternehmen:
Aktien: 37.33 Mio. St.
Frei handelbar: 70.47%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 5.2
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Neutral
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: -
KBV: 1.18
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: -
Operative Marge: -
Managementeffizenz:
Gesamtkaprendite: -73.44%
Eigenkaprendite: -92.47%
>PCI BIOTECH Peer Group

Es sind 25 Aktien bekannt.
 
29.08.25 - 07:03
PCI Biotech half-year interim 2025 report (GlobeNewswire EN)
 
Oslo (Norway), 29 August 2025 – PCI Biotech (OSE: PCIB), today announces its half-yearly 2025 interim report. Please find enclosed the interim report and presentation....
26.08.25 - 16:18
PCI Biotech: Invitation to first half 2025 results presentation and corporate update (GlobeNewswire EN)
 
Oslo, Norway, 26 August 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2025 interim report on Friday, 29 August 2025, 08:30am – 09:00am CET (local time). ...
22.08.25 - 14:18
Flaggemelding (GlobeNewswire EN)
 
Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding ASA....
22.08.25 - 11:12
Flaggemelding (GlobeNewswire EN)
 
Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag kjøpt 240 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS 2 000 000 aksjer, noe som utgjør 5,36% av aksjene i PCI Biotech Holding ASA....
18.08.25 - 20:42
PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations (GlobeNewswire EN)
 
Oslo (Norway), 18 August 2025 – PCI Biotech Holding ASA (PCI Biotech, OSE:PCIB) today announces the discontinuation of development of the photochemical lysis (PCL) technology for viral vector manufacturing. ...
22.05.25 - 11:48
PCI Biotech: Minutes of Annual General Meeting 2025 (GlobeNewswire EN)
 
Oslo, 22 May 2025. The Annual General Meeting in PCI Biotech Holding ASA took place today, 22 May 2025. ...
20.05.25 - 22:12
PCI BIotech: Disclosure of voting rights for Chair of the Board (GlobeNewswire EN)
 
Oslo, 20 May 2025. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors....
30.04.25 - 10:03
Notice of Annual General Meeting 2025 (GlobeNewswire EN)
 
Oslo, Norway, 30 April 2025 - The annual general meeting of PCI Biotech Holding ASA will be held at the company's office at Oslo Cancer Cluster Innovation Park on 22 May 2025 at 10:00am (CEST)....
24.04.25 - 17:33
PCI Biotech Holding ASA: Annual Report 2024 (GlobeNewswire EN)
 
Oslo, Norway, April 24, 2025The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2024. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2024 is also available on the company's website www.pcibiotech.com....
27.02.25 - 07:03
PCI Biotech full year 2024 interim results (GlobeNewswire EN)
 
Oslo (Norway), 27 February 2025 – PCI Biotech (OSE: PCIB), today announces its preliminary full year 2024 results. Please find enclosed the interim report and presentation....
25.02.25 - 09:00
PCI Biotech: Invitation to preliminary full-year 2024 results presentation (GlobeNewswire EN)
 
Oslo, Norway, 25 February 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's full-year 2024 interim report on Thursday 27 February 2025, 08:30am – 09:00am CET (local time). ...
10.01.25 - 10:27
PCI Biotech: Employee share option scheme in connection with promotion of new CSO (GlobeNewswire EN)
 
Oslo, 10 January 2025 - PCI Biotech (OSE: PCIB), today announced that the Board of Directors has granted share options to Morten Luhr who has been promoted to Chief Scientific Officer (CSO) from January 2025. Anders Høgset, former CSO, will commence as Scientific Advisor in a 20% position....
02.09.24 - 07:57
PCI Biotech: Employee share option scheme (GlobeNewswire EN)
 
Oslo, 2 September 2024 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees.        ...
28.08.24 - 07:03
PCI Biotech first half 2024 interim results (GlobeNewswire EN)
 
Oslo (Norway), 28 August 2024 – PCI Biotech (OSE: PCIB), today announces its interim first half 2024 results. Please find enclosed the interim report and presentation.Highlights review...
23.08.24 - 09:39
PCI Biotech: Invitation to first half interim 2024 results presentation (GlobeNewswire EN)
 
Oslo, Norway, 23 August 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2024 interim report on Wednesday 28 August 2024, 08:30am – 09:00am CEST (local time)....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Zwei Dinge bedrohen ständig die Welt: Die Ordnung und die Unordnung. - Paul Ambroise Valéry
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!